Datasets:
title: 'House Oversight: Estate Documents (Nov 12) (HOUSE_OVERSIGHT_024763)'
source: 'House Oversight: Estate Documents (Nov 12)'
sourceUrl: https://www.justice.gov/epstein
date: '2026-01-01'
category: House Oversight
eftaNumber: HOUSE_OVERSIGHT_024763
ocrPages: 1
ocrChars: 2168
ocrElapsed: 0
parseTier: external-legacy
engine: engine undisclosed (ep-nov-12.greg.technology mirror)
externalSource: greg-ep-nov-12
externalLicense: not granted
externalCredit: ep-nov-12.greg.technology
externalUrl: https://ep-nov-12.greg.technology
ACKRELL CAPITAL CHAPTER VII Capital Markets for Cannabis Companies Public Capital Markets: Canada As of November 30, 2017, six cannabis-related companies were trading on the TSX, 20 were trading on the TSXV and 41 were trading on the CSE. Most of the publicly traded cannabis-related companies in Canada are licensed producers under Canada's Access to Cannabis for Medical Purposes Regula- tions, which allow a company to produce and sell medical cannabis products in Canada. A number of companies traded on the CSE also have cannabis-related operations in the United States. The following table provides a summary of cannabis-related companies traded on Canadian stock markets. (As of November 30, 2017) Summary of Canadian Publicly Traded Cannabis-Related Companies Average ($U.S. millions) Number of Companies Market Value Enterprise Value Cash Debt LTM LTM Revenue EBITDA Toronto Stock Exchange (TSX) TSX Venture Exchange (TSXV) Canadian Securities Exchange (CSE) Canada 6 20 41 67 $1,361.5 131.5 72.6 $210.6 $1,311.4 123.9 72.0 $203.3 $71.0 10.8 2.0 $11.1 $20.8 3.3 1.4 $3.8 $26.6 1.2 1.8 $4.0 $0.8 -3.5 -2.8 -$2.2 Source: S&P Global Market Intelligence. Companies that are traded on more than one market are included in their primary market as determined by S&P Global Market Intelligence, based on stock price history, trading volume and availability of estimates. Enterprise Value is defined as Market Value plus Debt minus Cash and Cash Equivalents. LTM is Last Twelve Months. EBITDA is defined as Earnings Before Interest, Taxes, Depreciation Stock Price Performance of Canadian Publicly Traded Cannabis-Related Companies The following chart shows the stock price performance of selected publicly traded cannabis-related companies in Canada since September 30, 2016. The chart indicates that the stock price performance of cannabis-related companies trading on Canadian markets received a boost from the announcement of the proposed recreational cannabis legislation in Canada by Prime Minister Justin Trudeau and, more recently, from Constellation Brands' investment in Canopy Growth. © 2017 Ackrell Capital, LLC Member FINRA/SIPC 127 HOUSE_OVERSIGHT_024763